STOCK TITAN

Quanterix to Present at Canaccord Genuity 43rd Annual Growth Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Quanterix Corporation (NASDAQ: QTRX) to Present at Canaccord Genuity 43rd Annual Growth Conference
Positive
  • None.
Negative
  • None.

BILLERICA, Mass.--(BUSINESS WIRE)-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will be presenting at the Canaccord Genuity 43rd Annual Growth Conference on August 10, 2023 at 12 p.m. EST.

The presentation will be available virtually and participants can register here: here. The presentation will be available following the conference on Quanterix’s website here: ir.quanterix.com.

To learn more about Quanterix, visit www.quanterix.com/about. To learn more about Quanterix’s Simoa® technology, visit: https://www.quanterix.com/simoa-technology/.

About Quanterix

From discovery to diagnostics, Quanterix’s ultrasensitive biomarker detection is fueling breakthroughs only made possible through its unparalleled sensitivity and flexibility. The Company’s Simoa® technology has delivered the gold standard for earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the Limit of Quantification (LoQ) of conventional analog methods. Its industry-leading precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Quanterix has been a trusted partner of the scientific community for nearly two decades, powering research published in more than 2,000 peer-reviewed journals. Find additional information about the Billerica, Massachusetts-based company at https://www.quanterix.com or follow us on Twitter and LinkedIn.

Media:

PAN Communications

Maya Nimnicht

510-334-6273

quanterix@pancomm.com

Investor Relations:

Ed Joyce

(610) 306-9917

ir@quanterix.com

Source: Quanterix Corporation

FAQ

What event is Quanterix Corporation presenting at?

Quanterix Corporation will be presenting at the Canaccord Genuity 43rd Annual Growth Conference on August 10, 2023 at 12 p.m. EST.

Where can participants register for the virtual presentation?

Participants can register for the virtual presentation at the following link: [link].

Where will the presentation be available following the conference?

The presentation will be available on Quanterix's website at the following link: [link].

Quanterix Corporation

NASDAQ:QTRX

QTRX Rankings

QTRX Latest News

QTRX Stock Data

647.14M
32.52M
8.72%
85.23%
2.63%
Testing Laboratories
Professional, Scientific, and Technical Services
Link
United States of America
BILLERICA

About QTRX

quanterix offers an ultra-sensitive diagnostic platform capable of measuring individual proteins at concentrations 1000 times lower than the best immunoassays available today. the single molecule array (simoa™) technology at the heart of the platform enables the detection and quantification of biomarkers previously difficult or impossible to measure, opening up new applications to address significant unmet needs in life science research, in-vitro diagnostics, companion diagnostics, blood screening, and more. quanterix is a venture capital backed company and the exclusive licensee of a broad intellectual property portfolio initially developed at tufts university by dr. david walt, scientific founder of quanterix and illumina (nasdaq: ilmn).